After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Verve Therapeutics Inc is $424.44M. A total of 5.62 million shares were traded on the day, compared to an average of 2.65M shares.
In the most recent transaction, Kathiresan Sekar sold 9,822 shares of VERV for 4.15 per share on Apr 02 ’25. After the transaction, the Chief Executive Officer now owns 346,686 company shares. In a previous transaction on Apr 02 ’25, Nickerson Joan sold 2,777 shares at 4.15 per share. VERV shares that Chief Administrative Officer owns now total 17,420.
Among the insiders who sold shares, Ashe Andrew D. disposed of 2,681 shares on Apr 02 ’25 at a per-share price of $4.15. This resulted in the insider holding 348,828 shares of VERV after the transaction. In another insider transaction, Politi Jason sold 3,235 shares at $4.15 per share on Apr 02 ’25. Company shares held by the Chief Technical Ops. Off. now total 14,226.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, VERV has a high of $9.31 and a low of $2.86.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. VERV’s latest balance sheet shows that the firm has $360.44M in Cash & Short Term Investments as of fiscal 2021. There were $1.96M in debt and $22.02M in liabilities at the time. Its Book Value Per Share was $5.56, while its Total Shareholder’s Equity was $357.35M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VERV is Buy with a score of 4.70.
